Literature DB >> 31853454

Cancer stem cells and nanotechnological approaches for eradication.

Gholam Basati1, Mojtaba Khaksarian2, Saber Abbaszadeh3, Hamed Esmaeil Lashgarian4, Abdolrazagh Marzban5.   

Abstract

Cancer stem cells (CSCs) are currently known as the main cause of tumor recurrence. After chemotherapy is completed, CSCs proliferate and then differentiate to generate new tumor tissues. Similar to normal stem cells, this non-uniformly distributed cell population in the tumor tissue has self-renewal capacity and is responsible for survival of the tumor and difference in its genetic and metabolic characteristics. Followed by gene instability in CSCs, new phenotypic markers are aberrantly expressed in CSCs subpopulation. Hence, some of the surface markers and metabolic pathways that are upregulated in CSCs may be applied as specific targets for development of diagnostic and therapeutic approaches. In this review article, the distinctive properties of CSCs including signal pathways implicated in self-renewal and surface markers were discussed. Moreover, targeting CSCs based on their specific properties using nanodrugs was reviewed. 2019 Stem Cell Investigation. All rights reserved.

Entities:  

Keywords:  Cancer stem cells (CSCs); nano-formulations; self-renewal; surface markers

Year:  2019        PMID: 31853454      PMCID: PMC6917554          DOI: 10.21037/sci.2019.10.07

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


  119 in total

1.  CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma.

Authors:  Lian Shu Piao; Wonhee Hur; Taek-Kyun Kim; Sung Woo Hong; Sung Woo Kim; Jung Eun Choi; Pil Soo Sung; Myeong Joon Song; Byeong-Chel Lee; Daehee Hwang; Seung Kew Yoon
Journal:  Cancer Lett       Date:  2011-10-23       Impact factor: 8.679

2.  Molecular Imaging of CD44-Overexpressing Gastric Cancer in Mice Using T2 MR Imaging.

Authors:  Hwunjae Lee; Seung-Hyun Yang; Dan Heo; Heyoung Son; Seungjoo Haam; Jin-Suck Suh; Jaemoon Yang; Yong-Min Huh
Journal:  J Nanosci Nanotechnol       Date:  2016-01

3.  Nucleus-targeted nano delivery system eradicates cancer stem cells by combined thermotherapy and hypoxia-activated chemotherapy.

Authors:  Hongjuan Li; Weixiao Yan; Xiaomin Suo; Haotong Peng; Xinjian Yang; Zhenhua Li; Jinchao Zhang; Dandan Liu
Journal:  Biomaterials       Date:  2019-02-06       Impact factor: 12.479

Review 4.  Cancer stem cells and evolving novel therapies: a paradigm shift.

Authors:  Sangeetha Vasudevaraj Naveen; Kumar Kalaivani
Journal:  Stem Cell Investig       Date:  2018-01-23

Review 5.  Recombinant toxins for the treatment of cancer.

Authors:  Robert J Kreitman
Journal:  Curr Opin Mol Ther       Date:  2003-02

6.  Silencing of the ABCC4 gene by RNA interference reverses multidrug resistance in human gastric cancer.

Authors:  Guangyu Zhang; Zhenran Wang; Feng Qian; Chen Zhao; Chaowen Sun
Journal:  Oncol Rep       Date:  2014-12-30       Impact factor: 3.906

Review 7.  Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.

Authors:  Peyman Ranji; Tayyebali Salmani Kesejini; Sara Saeedikhoo; Ali Mohammad Alizadeh
Journal:  Tumour Biol       Date:  2016-08-26

8.  Developmental signaling pathways in cancer stem cells of solid tumors.

Authors:  Christina Karamboulas; Laurie Ailles
Journal:  Biochim Biophys Acta       Date:  2012-11-27

9.  Mechanisms of chemoresistance in cancer stem cells.

Authors:  Lissa Nurrul Abdullah; Edward Kai-Hua Chow
Journal:  Clin Transl Med       Date:  2013-01-17

10.  Nano Let‑7b sensitization of eliminating esophageal cancer stem‑like cells is dependent on blockade of Wnt activation of symmetric division.

Authors:  Yamei Pang; Jian Liu; Xiang Li; Yiwen Zhang; Boxiang Zhang; Jing Zhang; Ning Du; Chongwen Xu; Rui Liang; Hong Ren; Shou-Ching Tang; Xin Sun
Journal:  Int J Oncol       Date:  2017-08-29       Impact factor: 5.650

View more
  3 in total

1.  The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.

Authors:  Wen-Tao Wang; Tian-Qi Chen; Zhan-Cheng Zeng; Qi Pan; Wei Huang; Cai Han; Ke Fang; Lin-Yu Sun; Qian-Qian Yang; Dan Wang; Xue-Qun Luo; Yu-Meng Sun; Yue-Qin Chen
Journal:  J Hematol Oncol       Date:  2020-06-17       Impact factor: 17.388

2.  Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.

Authors:  Wei Wu; Jessica L Klockow; Michael Zhang; Famyrah Lafortune; Edwin Chang; Linchun Jin; Yang Wu; Heike E Daldrup-Link
Journal:  Pharmacol Res       Date:  2021-07-21       Impact factor: 10.334

Review 3.  Principles and innovative technologies for decrypting noncoding RNAs: from discovery and functional prediction to clinical application.

Authors:  Yu-Meng Sun; Yue-Qin Chen
Journal:  J Hematol Oncol       Date:  2020-08-10       Impact factor: 17.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.